These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8928167

  • 1. [Should Alzheimer disease be treated with tacrine? Review of the literature].
    Arsland D, Laake K.
    Tidsskr Nor Laegeforen; 1996 Sep 30; 116(23):2791-4. PubMed ID: 8928167
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease.
    Prescrire Int; 2001 Dec 30; 10(56):180-1. PubMed ID: 11824442
    [Abstract] [Full Text] [Related]

  • 4. Maximizing function in Alzheimer's disease: what role for tacrine?
    Smucker WD.
    Am Fam Physician; 1996 Aug 30; 54(2):645-52. PubMed ID: 8701842
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec 30; 12(68):230-1. PubMed ID: 14986699
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alzheimer's disease: the role of tacrine therapy.
    Jogerst G.
    Iowa Med; 1995 Oct 30; 85(10):409-11. PubMed ID: 7591656
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
    García-López MT, Guardado-Santervás P.
    Rev Neurol; 1995 Oct 30; 32(4):394-7. PubMed ID: 11398762
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tacrine therapy for the dementia of Alzheimer's disease.
    Manning FC.
    Am Fam Physician; 1994 Sep 15; 50(4):819-26. PubMed ID: 8079912
    [Abstract] [Full Text] [Related]

  • 15. Pharmacoepidemiology of tacrine in Alzheimer's disease.
    Begaud B, Haramburu F, Miremont G.
    Methods Find Exp Clin Pharmacol; 1996 Sep 15; 18 Suppl B():77-8. PubMed ID: 8899701
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity.
    Fontana RJ, Turgeon DK, Woolf TF, Knapp MJ, Foster NL, Watkins PB.
    Hepatology; 1996 Jun 15; 23(6):1429-35. PubMed ID: 8675160
    [Abstract] [Full Text] [Related]

  • 19. Cognition-enhancing drugs in dementia: a guide to the near future.
    van Reekum R, Black SE, Conn D, Clarke D.
    Can J Psychiatry; 1997 Jun 15; 42 Suppl 1():35S-50S. PubMed ID: 9220128
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.